指南与共识乳腺癌

乳腺癌新型全身治疗与放疗整合的国际多学科共识:欧洲放射肿瘤学会(ESTRO)认可的推荐

International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations.
指南 / 共识 · Lancet Oncol · 2024-01-01

针对乳腺癌新型全身治疗与放疗整合证据稀疏的问题,该多学科协作组梳理并总结文献,在缺乏具体证据处形成共识声明,并为后续研究中的放疗数据记录和质量保证提出最佳实践推荐。

要点

  • 新型全身治疗与放疗整合的临床证据稀疏,需多学科协作确保安全公平治疗。
  • 协作组由放射肿瘤、临床肿瘤、内科肿瘤、基础与转化科学家及患者倡导者组成。
  • 共识声明覆盖药物-放疗整合,并为后续研究放疗数据记录和质量保证提出最佳实践推荐。

核心结论

  • 针对乳腺癌新型全身治疗与放疗整合证据稀疏的现状,多学科协作组形成共识声明并为后续研究中的放疗数据记录和质量保证提出最佳实践推荐。

研究设计与样本

  • 欧洲放射肿瘤学会(ESTRO)认可的国际多学科共识,由放射肿瘤、临床肿瘤、内科肿瘤、基础与转化科学家及患者倡导者组成的协作组制定。

主要发现

  • 新型全身治疗正快速进入临床实践,其作用机制和副作用谱与传统化疗不同。
  • 支持这些新型全身治疗的关键临床试验主要关注全身治疗,因此关于放疗的数据稀疏。
  • 将新型全身治疗与放疗整合因此具有挑战性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出,支持新型全身治疗的关键临床试验主要关注全身治疗,因此关于放疗的数据稀疏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Novel systemic therapies for breast cancer are being rapidly implemented into clinical practice. These drugs often have different mechanisms of action and side-effect profiles compared with traditional chemotherapy. Underpinning practice-changing clinical trials focused on the systemic therapies under investigation, thus there are sparse data available on radiotherapy. Integration of these new systemic therapies with radiotherapy is therefore challenging. Given this rapid, transformative change in breast cancer multimodal management, the multidisciplinary community must unite to ensure optimal, safe, and equitable treatment for all patients. The aim of this collaborative group of radiation, clinical, and medical oncologists, basic and translational scientists, and patient advocates was to: scope, synthesise, and summarise the literature on integrating novel drugs with radiotherapy for breast cancer; produce consensus statements on drug-radiotherapy integration, where specific evidence is lacking; and make best-practice recommendations for recording of radiotherapy data and quality assurance for subsequent studies testing novel drugs.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Meattini I, Becherini C, Caini S, et al. International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations. Lancet Oncol. 2024. PMID: 38301705. doi:10.1016/S1470-2045(23)00534-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。